Volver a Agenda
Session Chair(s)
Stuart Russel Walker, PHD
Professor and Consultant
Centre for Innovation In Regulatory Science (CIRS), United Kingdom
Learning Objective : Discuss how companies and agencies engage with patients to determine the benefit-risk assessment of medicines; Describe how patients and patient advocacy groups would like to be involved in decision making; Compare and contrast the differences in each stakeholder’s perspective on patients’ involvement.
Speaker(s)
EMA Perspective
Hans-Georg Eichler, MD, MSC
Austrian Association of Social Security Bodies, Austria
Consulting Physician
FDA Perspective
John Whyte, DrMed, MD, MPH
WebMD, United States
Chief Medical Officer
Patient Perspective
Durhane Wong-Rieger, PHD, MA
Canadian Organization For Rare Disorders, Canada
President and Chief Executive Officer
¿Tiene una cuenta?